PMID- 29904406 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200930 IS - 1792-0981 (Print) IS - 1792-1015 (Electronic) IS - 1792-0981 (Linking) VI - 15 IP - 6 DP - 2018 Jun TI - Systematic review and meta-analysis of the efficacy and safety of Biqi capsule in rheumatoid arthritis patients. PG - 5221-5230 LID - 10.3892/etm.2018.6121 [doi] AB - Biqi capsule is a Traditional Chinese Medicine preparation for treating rheumatoid arthritis (RA), and clinical studies have indicatedthat its effect may be more beneficial than that of Western medicine. The present study aimed to estimate the efficacy and safety of Biqi capsule alone or combined with methotrexate (MTX) compared with MTX alone for treating RA by performing a meta-analysis of randomized controlled trials and controlled clinical trials. A systematic literature search of studies published until March 2017 was performed. References from relevant studies were screened to obtain additional articles. The results were independently evaluated for relevance, and full-text studies were assessed for eligibility. The risk of bias was assessed using the Cochrane collaboration tool for assessing risk of bias. Out of 558 citations that were initially retrieved, a total of 5 studies comprising 522 patients met the inclusion criteria. The risk of bias of these trials was generally unclear or high. Meta-analysis indicated that Biqi capsule had better effects on C-reactive protein [standardized mean difference (SMD), -7.05; 95% CI -(10.77-3.33)] and tender joint count [SMD, -3.02; 95% CI, -(3.81-2.22)] and fewer adverse effects (AEs) than MTX [relative risk (RR), 0.19; 95% CI, 0.08-0.43]. Biqi capsule plus MTX was superior to MTX in terms of the total effect (RR, 1.17; 95% CI, 1.06-1.28), rheumatoid factor [SMD, -12.54; 95% CI, -(16.87-8.20)], swollen joint count [SMD, -1.50; 95% CI, -(1.99-1.01)], score of joint swelling [SMD -2.07; 95% CI, -(2.76-1.38)], tender joint count [SMD, -2.16; 95% CI, -(2.86-1.47)] and score of joint tenderness [SMD, -4.69; 95% CI, -(5.92-3.47)]. There was no difference in AEs between Biqi capsule plus MTX and MTX (RR, 0.71; 95% CI, 0.34-1.50). In conclusion, the present study indicated that compared with MTX, Biqi capsule plus MTX appeared to have more benefits but that Biqi capsule alone was not better for RA patients than MTX. In the other words, Biqi capsule plus MTX is more effective and has fewer AEs compared to MTX. However, the trials selected in the present meta-analysis have various limitations, including the lack of blinding and the short duration of the treatment; therefore, the conclusions are not sufficiently definitive. More randomized controlled trials are necessary to evaluate the use of Biqi capsule for managing RA. FAU - Chen, Xiu-Min AU - Chen XM AD - Department of Rheumatology, The Second Affiliated Hospital, (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China. AD - Postdoctoral Mobile Research Station, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China. FAU - Wu, Jia-Qi AU - Wu JQ AD - Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China. FAU - Huang, Qing-Chun AU - Huang QC AD - Department of Rheumatology, The Second Affiliated Hospital, (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China. FAU - Zhang, Jian-Yong AU - Zhang JY AD - Department of Rheumatology, Shenzhen Hospital of Chinese Medicine, Shenzhen, Guangdong 518033, P.R. China. FAU - Pen, Jian-Hong AU - Pen JH AD - Department of Rheumatology, Dongguan Hospital of Chinese Medicine, Dongguan, Guangdong 523005, P.R. China. FAU - Huang, Zhi-Sheng AU - Huang ZS AD - Department of Rheumatology, Guangzhou Hospital of Chinese and Western Medicine, Huadu, Guangdong 510800, P.R. China. FAU - Chu, Yong-Liang AU - Chu YL AD - Department of Rheumatology, The Second Affiliated Hospital, (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China. FAU - He, Xiao-Hong AU - He XH AD - Department of Rheumatology, The Second Affiliated Hospital, (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China. FAU - Wang, Mao-Jie AU - Wang MJ AD - Department of Rheumatology, The Second Affiliated Hospital, (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China. FAU - Huang, Run-Yue AU - Huang RY AD - Department of Rheumatology, The Second Affiliated Hospital, (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, P.R. China. LA - eng PT - Journal Article DEP - 20180502 PL - Greece TA - Exp Ther Med JT - Experimental and therapeutic medicine JID - 101531947 PMC - PMC5996666 OTO - NOTNLM OT - Biqi capsule OT - herbal medicine OT - meta-analysis OT - rheumatoid arthritis OT - systematic review EDAT- 2018/06/16 06:00 MHDA- 2018/06/16 06:01 PMCR- 2018/05/02 CRDT- 2018/06/16 06:00 PHST- 2017/09/28 00:00 [received] PHST- 2018/03/01 00:00 [accepted] PHST- 2018/06/16 06:00 [entrez] PHST- 2018/06/16 06:00 [pubmed] PHST- 2018/06/16 06:01 [medline] PHST- 2018/05/02 00:00 [pmc-release] AID - ETM-0-0-6121 [pii] AID - 10.3892/etm.2018.6121 [doi] PST - ppublish SO - Exp Ther Med. 2018 Jun;15(6):5221-5230. doi: 10.3892/etm.2018.6121. Epub 2018 May 2.